Omega Healthcare Named “Star Performer” in Revenue Cycle Management (RCM) Operations PEAK Matrix® Assessment 2022
Marks the fifth year that Omega has been ranked as a market leader by Everest Group BOCA RATON, Fla., July 18, 2022 /PRNewswire/ -- Omega Healthcare, a leading healthcare management solutions partner supporting the broad healthcare ecosystem, was recently named "Star Performer" in Revenue Cycle Management (RCM) Operations PEAK Matrix® Assessment 2022...
Samsung Biologics to purchase land for its second Bio Campus
Acquires additional land, sized 357,366㎡ valued at KRW 426 billion, for Bio Campus 2 Plans to build Multi-Modal Plant, Open Innovation, and expanded manufacturing capacities INCHEON, South Korea, July 18, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), announced that it has signed a land purchase agreement with the...
BRONCUS COMPLETED SURGERIES ON THE FIRST GROUP OF PATIENTS USING ITS InterVapor®, THE THERMAL VAPOR TREATMENT SYSTEM, AFTER APPROVED FOR MARKETING IN CHINA
HANGZHOU, China, July 18, 2022 /PRNewswire/ -- Broncus Medical (02216.HK) has completed surgeries on the first group of patients using its InterVapor®(including InterVapor Generator and InterVapor Catheter, the "InterVapor®"), after it was approved for marketing in China. This marked the official entry of InterVapor® into the clinical commercialization phase in China and is expected to benefit patients with chronic obstructive...
AXA introduces the “BeOnTrack Programme”, an all-in-one solution for participants to restore and build a healthy lifestyle
Expert trio to formulate health improvement plans through professional consultations, self-monitoring and laboratory tests HONG KONG, July 18, 2022 /PRNewswire/ -- AXA Hong Kong and Macau (AXA) today announced the launch of its "BeOnTrack Programme" ("BeOnTrack" or the "Programme"). At only HKD10 per day, the expert trio will help formulate solutions, supporting participants to achieve their health goals and live healthier lives...
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics
Kinpeygo® (developed under the name NEFECON) is the first and only EMA- approved treatment for IgAN Everest Medicines has exclusive rights to develop and commercialize NEFECON in Greater China, Singapore and South Korea SHANGHAI, July 18, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), announced today that our partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm:...
Amaris B. Clinic Is Seeing More Patients for Liposuction Due To Inefficacy of Non-surgical Fat Reduction Treatments
Dr Ivan Puah, Medical Director at Amaris B. Clinic, has been performing modern liposuction and corrective surgeries for patients who have experienced less than satisfactory results from non-surgical treatments and those who suffer from PAH, a rare side effect of cryolipolysis. SINGAPORE, July 15, 2022 /PRNewswire/ -- Advancement in technology has led to the development of many fat...
China CDE Grants Breakthrough Therapy Designation (BTD) to Neurophth’s NR082 in LHON
WUHAN, China and SAN DIEGO, July 15, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc., ("Neurophth") today announced that the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has granted a Breakthrough Therapy Designation (BTD) to the Company's leading gene therapy drug candidate, NR082 (rAAV2-ND4), for the treatment of Leber's hereditary optic neuropathy (LHON) associated with...
Pulnovo Medical Concludes Successfully First Pre-Sub Meeting with FDA for PADN Global Clinical Trial
SHANGHAI, July 15, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pioneer in the treatment for cardiopulmonary diseases, today announced that it has successfully concluded the first Pre-Sub meeting with the U.S. Food and Drug Administration ("FDA") for its Pulmonary Artery Denervation (PADN) Global Trial. Dr. Shaoliang Chen, Chair of Pulnovo Medical's Scientific Advisory Board and pioneer...
Globe’s 917Ventures partners with AC Ventures to explore business opportunities, grow ecosystem
MANILA, Philippines, July 15, 2022 /PRNewswire/ -- Globe Capital Venture Holdings, Inc. (917Ventures), the corporate venture builder of top Philippine digital solutions platform Globe Telecom, has partnered with AC Ventures, a subsidiary of Filipino conglomerate Ayala Corp. (Ayala), to explore business opportunities and grow its ecosystem. AC Ventures is the conglomerate's platform for its investments in adjacent businesses that...
CStone Announces the NDA Approval of GAVRETO® (pralsetinib) for the Treatment of RET Fusion-Positive treatment-naïve (first-line) and pretreated Non-Small Cell Lung Cancer (NSCLC) in Hong Kong, China
GAVRETO is the first highly selective rearranged during transfection (RET) inhibitor approved in Hong Kong, China for the treatment of RET fusion-positive metastatic non-small cell lung cancer GAVRETO is CStone's second therapy approved in Hong Kong, China GAVRETO is CStone's ninth NDA approval in the Greater China region SUZHOU, China, July 15, 2022 /PRNewswire/ -- CStone Pharmaceuticals...
